key: cord-0885468-b5je6vlr
authors: Lacap, Eduardo M.; Varghese, Abraham; Khamis, Faryal; Bahrani, Maher Al; Naamani, Hamed Al; Kolamban, Shajidmon; Dowaiki, Samata Al; Shuaily, Huda Salim Al
title: Development and Validation of CoV19-OM Intensive Care Unit Score: An Early ICU Identification for Laboratory-Confirmed SARS-CoV-2 Patients from a Retrospective Cohort Study in Oman
date: 2021-04-24
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.04.069
sha: f227658f4d5092c86480ec21f9a184121e809ad6
doc_id: 885468
cord_uid: b5je6vlr

OBJECTIVE: To develop and validate a clinical score that will identify potential admittance in an intensive care unit (ICU) for a coronavirus disease 2019 (COVID-19) case. MATERIALS AND METHODS: The clinical scoring is built using Least Absolute Shrinkages and Selection Operator logistic regression. The prediction algorithm was constructed and cross-validated using the development cohort of 313 COVID-19 patients and was validated using independent retrospective set of 64 COVID-19 patients. RESULTS: Majority of patients are Omani in nationality (n=181, 58%). Multivariate logistic regression identified 8 independent predictors of ICU admission that were included in the clinical score: hospitalization (OR, 1.079; 95% CI, 1.058 - 1.100), absolute lymphocyte count (OR, 0.526; 95%CI, 0.379- 0.729), C-reactive protein (OR, 1.009; 95%CI, 1.006-1.011), lactate dehydrogenase (OR, 1.0008; 95%CI, 1.0004-1.0012), CURB-65 score (OR, 2.666; 95%CI, 2.212-3.213), chronic kidney disease with estimated glomerular filtration rate of less than 70 (OR, 0.249; 95%CI, 0.155-0.402), shortness of breath (OR, 3.494; 95%CI, 2.528-6.168), and bilateral infiltrates in chest radiography (OR, 6.335; 95%CI, 3.427-11.713). The mean of area under a curve (AUC) from the development cohort was 0.86 (95%CI, 0.85-0.87) and of the validation cohort was 0.85 (95%CI, 0.82-0.88). CONCLUSION: We provided a web application for identifying potential admittance in an ICU for COVID-19 case by clinical risk score based on 8 significant characteristics of patient (http://3.14.27.202/cov19-icu-score/).

Wuhan City, Hubei Province, People's Republic of China becomes the epicenter of the novel corona virus disease caused by severe acute respiratory syndrome corona virus 2 (SARS CoV-2) on December, 2019 (Huang et al., 2020; WHO, 2020) . The disease spread worldwide, and the positivity rate increases exponentially that the World Health Organization subsequently declare the disease as pandemic on March 11, 2020. In Sultanate of Oman, from 2 confirmed cases on February, 2020, the cases reaches 107,213 with 1,053 deaths as of October 13, 2020 . This figure translates to 0.98% mortality rate way below the global mortality rate of 2.83% . On the other hand, with the 8,624 sample hospitalization cases across the Sultanate, an 8.8% intensive care unit admission rate has been observed (Director General of Information Technology, Oman, 2020) . This creates a pressing problem if left undetected.

This study focuses on early identification of laboratory-confirmed coronavirus disease 2019 cases who are likely to progress and be admitted in an intensive care unit facility. The identification was being done using a retrospective study where the patients' demographic characteristics, medical J o u r n a l P r e -p r o o f history, symptoms, laboratory parameters on admission, radiological findings, and diagnosis on admission and ICU outcome were taken into account to build a model that would probabilistically identify their admittance to the ICU facility . This simple algorithm is expected to be of great help to clinical practitioners in managing their patients and medical resources that could lead to a better planning and optimization of limited human resources and physical facilities. The first part of this paper covered the methodology used in the study followed by results, discussion and conclusion drawn from the study.

Patients who were enrolled on this study were the reverse transcription polymerase chain reaction (RT-PCR) confirmed coronavirus disease 2019 cases from The Royal Hospital (RH) , Ministry of Health, Oman. A formal ethical approval for the conduct of the study has been granted by the Directorate General of Royal Hospital, Ministry of Health. The necessity of an informed consent was waived as the identity of the patients are masked and anonymized.

We obtain the patients' data from the RH medical records that was recorded in a structured flat data file. The data contains the patients' demographic characteristics, medical history, symptoms of COVID-19, laboratory parameters on admission, radiological findings, and diagnosis on admission and ICU outcome. Team of medical experts in RH cross-checked the veracity of the data. A total of 445 cases has been used as initial dataset from across several regions and municipalities in Oman. Data pre-processing and checking for zero variance variable have been executed which resulted to 313 final number of cases with 27 potential predictor variables.

J o u r n a l P r e -p r o o f

The development cohort contains several numbers of variables that are potentially associated with the admission in an intensive care unit. This is a classical problem where multicollinearity and over-fitting occur in a linear model. To address this issue, a variable selection technique using ℒ 1 regularization technique was executed. More specifically, a Least Absolute Shrinkage and Selection Operator (LASSO) was performed on all predictor variables with dichotomized ICU admission as the response variable. The regularization was tuned using the minimum value for .

To obtain the best fitting model, the development cohort was resampled using k-fold cross validation method. In this k-fold cross validation, the development cohort was partitioned into 10 nearly equally sized folds or groups wherein one of these 10 groups is selected as the testing set and the remaining 9 are merged and used as the training set. This approach was repeated 10 times to make sure that each fold is selected once as the testing set. The loss function used to select the best fitting model is the mean squared error. The model with the smallest mean squared error was selected as the final model and was used to the independent subjects for validation.

Descriptive and inferential statistics were used to explain the sample data and to infer about the population data, respectively. Categorical variables were reported using frequencies and percentages while continuous non-normal variables were reported using median and inter-quartile range (IQR). In addition, mean and standard deviation were used to present the continuous normal variables. Patients' records were divided into two memberships as either in Intensive Care Unit or not. This dichotomized variable served as the outcome variable in the study. To test the independence between the categorical predictor and the outcome variable, Pearson's 2 test and Fisher's exact test for 2 x 2 contingency table were used. Variables with violation in expected count, test of independence were not performed. For continuous variables, test of normality using J o u r n a l P r e -p r o o f Kolmogorov-Smirnov was implemented to assert normality in the data. For continuous nonnormal variables, the non-parametric Wilcoxon Mann-Whitney U test was used, otherwise Student's t was performed to test the significant difference between groups. Statistical significance is determine using level of significance at 0.05. A tolerance of at most 5% missing cases was enforced and median value imputation was imposed to the affected variable. Data analysis were carried out using the open-source statistical package R version 3.6.

A total of 313 pre-processed development cohort of coronavirus disease 2019 patients were gathered from The Royal Hospital from different municipalities across the Sultanate of Oman between March 9, 2020 to July 20, 2020. Using the development cohort, 141 out of 313 (45%) were admitted in an intensive care unit facility either on admission or as their infection progresses during hospitalization. Majority of the patients belong to age group 41-70 years old (n=181, 58%) and male patients (n=210, 67%) dominates the cohort and overall, mostly are Omani nationals (n=201, 64%). Observed mortality rate on the development cohort was 48 out of 313 (15%). A total of 225 (72%) were considered as low-risk based on their CURB-65 score on admission. On the other hand, 81 out of these 225 were eventually admitted in an ICU facility which represents more than half (81/151, 57%) of the total ICU cases. Hypertension (n=145, 46%) and diabetes mellitus (n=139, 44%) were the top 2 observed medical history among patients. In addition, fever (n=237, 76%) and shortness of breath (n=221, 71%) were the most common symptoms that were observed upon admission of the patients. Top 3 diagnosis on admission were pneumonia (n=210, 67%), severe pneumonia (n=210, 67%) and acute respiratory distress syndrome (ARDS) (n=210, J o u r n a l P r e -p r o o f 67%), respectively. Consequently, some 20 (7%) patients were considered asymptomatic upon admission.

Twenty-seven potential variables gathered upon hospital admission were subjected to a regularization procedure using LASSO to treat potential multicollinearity and over-fitting among these variables associated with ICU admission ( Table 1) . The LASSO procedure produced 11 independent variables using a minimum =0.02 as the tuning parameter to regularize all variables.

These includes demographic profile, medical history, symptoms, laboratory parameters on admission and chest radiographic results. More specifically, age group, hospitalization period, nationality, CURB-65 score, shortness of breath, bilateral infiltrates as chest X-ray abnormality, absolute lymphocyte count, c-reactive protein, d-dimer, chronic kidney disease and lactate dehydrogenase were identified as significant predictors.

These 11 identified variables were inputted in a logistic regression with backward elimination approach. The logistic regression model building needed to undergo internal cross validation. To be more specific, the best fitting model was estimated using 10-fold cross validation. In this 10fold cross validation, the development cohort was partitioned into 10 nearly equally sized folds.

Subsequent 10 iterations of training group and testing group are performed such that within each iteration, a different fold of the data is held out for testing, while the remaining 9 folds are used for parameter estimates. These procedures produced the best fitting model which resulted in 8 independently and statistically significant predictors of ICU admission. The clinical score Cov19 -OM ICU was determined using the following predictors: hospitalization period (OR=1.079; 95% shortness of breath (OR=3.949; 95% CI, 2.528 -6.168; p=.002), and bilateral infiltrates abnormality in chest X-ray (OR=6.335; 95% CI, 3.427 -11.713; p =.003) ( Table 2) .

After solving the multicollinearity and over-fitting among potential predictor variables using the Least Absolute Shrinkage and Selection Operator, a multivariate logistic regression has been used on the remaining 8 variables to arrive at the final coefficients for the CoV19-OM ICU score calculation. During the model building, we define ̂ as the estimate of the probability of admitting in an ICU. Following this definition, equation (1) An online web application has been created to fully automate the calculation of the CoV19-OM ICU score. This will allow the clinical practitioners to capitalize the simplicity of the graphical user interface by entering the require values for each variable while the intricacy of calculation is handled by the hosting server (http://3.14.27.202/cov19-icu-score/, see Figure 1a ). The web app will calculate three metrics based on the model given by (1). The CoV19-OM ICU score ranges from 1 to 5, the risk groupings from low risk, moderate risk, and high-risk groups. In addition, the predicted probability of being admitted in an intensive care unit facility is also provided ranging from 0% to 100% 

The validation data set included 64 retrospective patients. These patients are independent of the development cohort. Majority of the patient's age ranges from 41 to 70 years old and about 4 out of 5 patients were male. In this cohort, the percentage of Omani national was 42% (n=27) and the percentage of ICU admission among laboratory-confirmed COVID-19 cases was 70% (n=45).

Significant variables used in the proposed clinical score's calculation was shown in Table 3 . The clinical score's accuracy in the validation cohort was 0.85 (95% CI, 0.82-0.88).

The primary concern of this study was to investigate the association of demographic and clinical characteristics, medical history, laboratory parameter on admission and chest radiography result of the laboratory-confirmed COVID-19 cases to their admittance in an intensive care unit facility.

Majority of the patients were middle ages of which mostly are male in gender. This distribution among patients with respect to their age and gender were also similar to a number of studies (Galloway et al., 2020; . In contrary to some studies where age and gender were statistically associated with a severe classification of COVID-19 case (Galloway et al., 2020; Liang et al., 2020; Zhou et al., 2020) , this study find out a non-significant association between these two demographic variables with admission to ICU is concern. This non-significance was also achieved in a number of studies where clinical score was also being developed (Ji et al., 2020; Meylan et al., 2020) .

The median hospitalization period of all patients was 8 days while those patients who were admitted in ICU had a lower quartile and median hospitalization period of 9 and 14 days, respectively. A statistically significant difference was found in hospitalization period between ICU and non-ICU patients. On the other hand, majority of the patients were having a low-risk status upon hospital admission based on their CURB-65 score although a number of these progresses to severe classification of COVID-19 and eventually admitted in an ICU. The difference between the CURB-65 score with respect to admission to ICU and non-admission is statistically significant.

This indicates that along with hospitalization period, CURB-65 score is also a risk factor for ICU findings. Other studies in literature had similar findings with regards to the clinical score's importance in determining severity in COVID-19 patients (Oktariani, et al., 2019; Satici et al., 2020) .

In our study, the most common medical history of the patients were hypertension and diabetes mellitus. The elevated prevalence of these co-morbidities was widely documented in several papers where they highlighted the co-existence of these non-communicable diseases with a J o u r n a l P r e -p r o o f communicable COVID-19 disease (Barber, 2020; Shibata et al., 2020) . The association of these top co-morbidities, on the other hand, was not established in this paper.

The study covers a vast array of potential variables that would essentially be associated with the patient's admission to an ICU facility. This retrospective study has a very limited number of complete variable cases and some of the variables are being dropped due to the significant number of missing cases. Some of the dropped variables in the study were smoking and body mass index factors. It is interesting to note that other studies in literature have been wildly considering these two variables to contribute significantly in severity progression and ICU admission (Baronio et al., 2020; Caliskan & Saylan, 2020) . The absence of these variables is a limitation of the study since these variables may or may not be a good source of variation that could potentially deliver a different model as compared to the model presented on this paper.

This retrospective study provided a web application for identifying potential admittance in an intensive care unit facility for a laboratory-confirmed coronavirus disease 2019 case by integrating the developed and validated proposed clinical score based on 8 significant characteristics of the patient. The utilization of this web app will enable the health care provider to execute appropriate supportive care and to maximize the use of available intensive care unit facility in the hospital. On the other hand, it is interesting to note that generalizability is a limitation of the study due to relatively small sample sizes used for the training, testing, and validation cohorts. The dataset used for the proposed clinical score is limited to the Sultanate of Oman cases which may return an inconclusive result if used by other territories and states. Validation study is encouraged to be undertaken outside Sultanate's territory to generalize the efficiency of the clinical score. 

COVID-19 and diabetes mellitus: implications for prognosis and clinical management

Italian SARS-CoV-2 patients in intensive care: towards an identikit for subjects at risk?

Smoking and comorbidities are associated with COVID-19 and mortality in 565 patients treated in Turkey: a retrospective observational study

An interactive web-based dashboard to track COVID-19 in real time

A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

A predictive model for disease progression in non-severely ill patients with coronavirus disease 2019

Clinical characteristics and outcomes of the first 63 adult patients hospitalized with COVID-19: An experience from Oman

Epidemiology of COVID-19 infection in Oman: Analysis of the first 1304 cases

A simple algorithm helps early identification of SARS-CoV-2 infection patients with severe progression tendency

Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

An Early Warning Score to predict ICU admission in COVID-19 positive patients

CURB 65 score as a predictor of early mortality in hospital-acquired pneumonia

Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19

Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19

WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study